Altimmune (ALT) Revenue (2010 - 2025)
Altimmune (ALT) posted quarterly Revenue of $26000.0 for Q4 2025, up 420.0% year-over-year from $5000.0 in Q4 2024, and up 420.0% quarter-over-quarter from $5000.0 in Q3 2025.
Powered by 
Analysis
Altimmune (ALT) Revenue (2010 - 2025) Analysis & Trends
Altimmune (ALT) has reported Revenue for 16 consecutive years, with $26000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Revenue rose 420.0% year-over-year to $26000.0; the TTM figure through Dec 2025 stood at $41000.0 (up 105.0% YoY), while the FY2025 annual figure was $41000.0, up 105.0% from the prior year.
- Revenue advanced to $26000.0 in Q4 2025 per ALT's latest filing, from $5000.0 in the prior quarter.
- Across five years, Revenue topped out at $3.3 million in Q4 2021 and bottomed at $2000.0 in Q3 2022.
- Historically, Revenue has averaged $248250.0 across 5 years, with a median of $14500.0 in 2022.
- Annual changes were most pronounced in 2022 — Revenue tumbled 99.21% — and 2023, when it jumped 18000.0%.
- Altimmune's Revenue stood at $3.3 million in 2021, then sank by 99.21% to $26000.0 in 2022, then surged by 42.31% to $37000.0 in 2023, then slumped by 86.49% to $5000.0 in 2024, then soared by 420.0% to $26000.0 in 2025.
- Business Quant data shows ALT's Revenue at $26000.0 in Q4 2025, $5000.0 in Q3 2025, and $5000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.70 Bn | 58.52 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 57.56 Bn | 52.42 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.16 Bn | 35.06 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.63 Bn | 32.32 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.63 Bn | 27.79 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.73 Bn | 26.57 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Altimmune | 610.11 Mn | 610.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 26,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 37,000.00 |
| Sep 30, 2023 | 362,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Dec 31, 2022 | 26,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 32,000.00 |
| Dec 31, 2021 | 3.28 Mn |
| Sep 30, 2021 | 158,000.00 |
| Jun 30, 2021 | 137,000.00 |
| Mar 31, 2021 | 838,000.00 |